Introduction
Lactoferricin is a potent antimicrobial peptide released from the N-terminal part of lactoferrin by gastric pepsin cleavage. Lactoferricin B (Lfcin B) consists of 25 amino acids corresponding to residues 17-41 from the N-terminus of bovine lactoferrin. 1 The primary sequence of Lfcin B contains many hydrophobic and positively charged residues, indicating that it may interact with biological membranes. 2 It is thought that its main activity is on the cytoplasmic membrane. 1, 3 We report in this study a possible post-antibiotic effect (PAE) of Lfcin B (17-41) and two shorter derivatives, L-Lfcin B (17-31) and D-Lfcin B (17-31) on Escherichia coli and Staphylococcus aureus.
Materials and methods

Strains
We used the bacterial strains E. coli ATCC 25922 and S. aureus ATCC 25923, and two clinical isolates each of E. coli and of S. aureus. The bacteria were stored at Ϫ70ЊC. The bacteria were grown in 2% bacto peptone water (Difco, Detroit, MI, USA) pH 6.8. We used bacteria in the mid-logarithmic growth phase.
Peptides
Synthetic Lfcin B (17-41) was a gift from Wayne Bellamy (Nutritional Science Laboratory, Morinaga Milk Industry Co. Ltd, Kanawaga 228, Japan). The sequence of this peptide is NH 2 -Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-ArgMet-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-ArgArg-Ala-Phe-COOH. Two derivatives, L-Lfcin B (17-31) and D-Lfcin B (17-31), consisting of the same 15 amino acids, all L or all D amino acids, respectively, were synthesized on solid phase using fluorenylmethoxycarbonyl (Fmoc) chemistry, analysed and purified by high-performance liquid chromatography. The sequence of these peptides is NH 2 -Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-ArgMet-Lys-Lys-Leu-Gly-Ala-COOH. The peptides were diluted in sterile, distilled water to a concentration 100 times higher than the desired test concentrations and stored at Ϫ20ЊC. The final concentrations used were 5 ϫ MIC for each combination of peptide and bacteria.
MIC and MBC determination
Determination of MIC and MBC was carried out in parallel as described by Vorland et al. 4 
PAE procedure
The drug removal technique described by McDonald et al. 5 involving centrifugation and washing was used, with some adjustments. The test procedures were performed in a total volume of 1 mL. The bacteria were grown at 37ЊC with shaking in a water bath to log phase (10 7 -10 8 cfu/mL). Two tubes (A, the test tube; B, the control tube) were treated the same throughout the procedure. The concentration of bacteria in each test tube was 10 7 cfu/mL at time zero. The tubes were incubated at 37ЊC with shaking in a water bath Lactoferricin is an antimicrobial peptide generated by gastric pepsin cleavage of lactoferrin. A possible post-antibiotic effect (PAE) of bovine lactoferricin (Lfcin B) and two shorter peptide derivatives against Staphylococcus aureus and Escherichia coli was studied. A drug removal technique involving centrifugation and washing was used. No PAE was found for Lfcin B against these two bacteria. The shorter derivatives had a short PAE against E. coli. They had a short negative PAE against S. aureus. In conclusion, the overall PAE is not overwhelming, but the small differences found between the different peptide-bacteria combinations could indicate that different peptide mechanisms of action might be present. for 1 h. At the end of this exposure period the tubes were centrifuged for 10 min at 1200g. The bacterial suspensions were washed and centrifuged three times. Following this drug removal procedure, the bacterial suspension was transferred to polystyrene round-bottomed tubes. To check whether the bacterial growth in the control tube might be inhibited by the density of bacteria, in some cases we established a second control tube (b) after the drug removal procedure. This tube contained 100 L of the bacterial solution from control tube B, diluted 1/10 in 900 L prewarmed growth medium. The tubes were further incubated under the same conditions until turbidity was observed by eye.
The bacteria were counted at time zero, before and after the washing procedure and every 1 h thereafter. At each sampling time 10 L of bacterial solution was transferred to cold 0.9% NaCl, serially diluted and plated on PDM agar (Paper Disk Method Antibiotic Sensitivity Medium II; AB Biodisk, Solna, Sweden). The plates were incubated overnight at 37ЊC. The colonies were counted and the cfu/mL and the logarithms of the cfu/mL calculated. The PAE was estimated using the formula PAE ϭ T -C, where T is the time required for the test culture to increase 1 log 10 (10-fold) from the count observed immediately after the drug removal and C is the time required for 1 log 10 increase in the control tube. Each experiment, with its control, was carried out in triplicate.
Competition assay
Competition assays between teichoic acid (TA) and the short peptides were performed as described by Vorland et al. 4 We used the bacterial strain S. aureus ATCC 25923 at 1 ϫ 10 4 cfu/mL. The concentration range for TA in the microtitre tray was 0-1 mg/L. The concentration range for the peptides was 0-40 mg/L.
Results
The results of the PAE experiments are shown in Tables 1  and 2 . Lfcin B (17-41) showed no significant PAE on S. aureus or E. coli. The shorter peptide derivatives had a short PAE on E. coli. We found a slightly negative PAE on S. aureus for the short derivatives Lfcin B (17-31), more pronounced for the peptide made of all L amino acids than its counterparts made of all D amino acids.
In the competition assays we found that with increasing amount of TA, an increasing amount of both the D-and the L-Lfcin B (17-31) was necessary to obtain a growthinhibiting effect on the bacteria.
Discussion
Factors that may affect PAE are described by Craig et al. 6 It is suggested that the degree of PAE might be related to 8 have suggested that perhaps all cells are not hit by the peptides. This might be owing to an aggregation of the peptides, rendering the active part of them much smaller. The cells that are hit could be effectively killed, but cells that are not hit may divide, unaffected by the peptides.
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The shorter peptide derivatives had a short negative PAE on S. aureus, the L form more than the D form. Lfcin B (17-41) binds to teichoic acid. 4 It is suggested that autolysin binds to TA. 9 Our competition studies indicated that the D-and the L-Lfcin B (17-31) bind to TA. The binding of these peptides to TA may inhibit the binding of autolysin to TA. Septa may be made, but the cells will not separate owing to the missing action of autolysins. This may result in the formation of pseudomulticellular bacteria, which may contain many genomes, as described by Lorian. 10 As the peptide is removed, autolysin may bind to TA, thereby completing the cell separation.
Proteases may break down the peptides, thereby releasing amino acids as an extra substrate source in this culture, giving the bacteria an advantage as compared with the control culture, thereby creating a negative PAE. A peptide consisting of all L amino acids is more easily broken down by proteases than a peptide made of all D amino acids. Our finding of the more negative PAE for the L form is consistent with this presumption.
The negative PAE might be a false result owing to a bacterial density that is potentially too high in the control tube, giving these bacteria suboptimal growth conditions. Dilution of these control cultures (tubes b), however, gave the same results, contradicting this assumption.
